GSK-3 Glycogen synthase kinase 3

Inhibitors

Cat.No.	Name	Information
M1692	CHIR-99021	CHIR-99021 (CT99021) is an aminopyrimidine derivative that inhibits GSK3α and GSK3β with IC50 values of 10 and 6.7 nM, respectively.
M2304	TWS119	TWS119 is a GSK-3β inhibitor with IC50 of 30 nM.
M1989	CHIR-99021 HCl	CHIR-99021 HCl (CT99021) is a hydrochloride of CHIR-99021, with IC50 of 10 nM and 6.7 nM for GSK-3α and GSK-3β, respectively.
M10548	TSPC	TSPC (HUN86320) is a Glycogen Synthase Kinase-3β Inhibitor (GSK-3β Inhibitor).
M10531	BRD3731	BRD3731 is a selective GSK3β inhibitor, with IC50s of 15 nM and 215 nM for GSK3β and GSK3α, respectively.
M10530	BRD0705	BRD0705 is a potent, paralog selective and orally active GSK3α inhibitor with an IC50 of 66 nM and a Kd of 4.8 μM.
M10108	Indirubin-3'-monoxime	Indirubin-3'-monoxime is a potent GSK-3β inhibitor with IC50 of 22 nM, and inhibits Cdk5/p35, Cdk1/cyclin-B and Cdk2/cyclin-E with IC50s of 100, 180, 250 nM.
M8228	Bikinin	Bikinin is a strong activator of brassinosteroid (BR) signaling.
M7627	BIO	BIO (GSK-3 Inhibitor IX, 6-bromoindirubin-3-oxime, 6-Bromoindirubin-3'-oxime, MLS 2052) is a specific GSK-3 inhibitor, the IC50 acting on GSK-3α/β in cell-free assays is 5 nM, which is more than 16 times more selective than ACTing on CDK5. It is also a pan-JAK inhibitor with an IC50 value of 30 nM for Tyk2. BIO induces apoptosis in human melanoma cells.
M6594	CHIR 99021 trihydrochloride	CHIR 99021 trihydrochloride is a hydrochloride salt of CHIR 99021; selective GSK-3 inhibitor.
M3691	IM-12	IM-12 is a potent and selective GSK-3β inhibitor with IC50 of 53 nM, which also enhances canonical Wnt signalling.
M3442	SB415286	SB415286 is a potent GSK3α inhibitor with IC50/K_i of 78 nM/31 nM with equally effective inhibition of GSK-3β.
M3054	TDZD-8	TDZD-8 is a non-ATP competitive GSK-3β inhibitor with IC50 of 2 μM; minimal inhibitory effect observed on CDK1, casein kinase II, PKA and PKC.
M2826	LY2090314	LY2090314 is a potent GSK-3 inhibitor for GSK-3α/β with IC50 of 1.5 nM/0.9 nM; may improve the efficacy of platinum-based chemotherapy regimens. Phase 1/2.
M2417	AZD1080	AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with K_i of 6.9 nM and 31 nM, respectively.
M2405	AR-A014418	AR-A014418 is an ATP-competitive, and selective GSK3β inhibitor with IC50 and K_i of 104 nM and 38 nM, without significant inhibition on 26 other kinases tested.
M2354	1-Azakenpaullone	1-Azakenpaullone is a potent and selective GSK-3β inhibitor with IC50 of 18 nM, >100-fold selectivity over CDK1/cyclin B and CDK5/p25.
M2306	Tideglusib	Tideglusib (NP031112, NP-12) is a potent non ATP-competitive inhibitor of GSK3 with IC50 of 60 nM.
M2305	CHIR-98014	CHIR-98014 is a potent and selective GSK-3 inhibitor for GSK-3ɑ and GSK-3β with IC50 of 0.65 nM and 0.58 nM, respectively.
M2304	TWS119	TWS119 is a GSK-3β inhibitor with IC50 of 30 nM.
M2184	Indirubin	Indirubin is a potent cyclin-dependent kinases and GSK-3β inhibitor with IC50 of ~75 nM and 0.19 μM.
M2178	AZD2858	AZD2858 is a potent, orally bioactive inhibitor of GSK-3 with an IC50 of 68 nM.
M2061	SB 216763	SB 216763 is a potent and selective, cell permeable glycogen synthase kinase-3 (GSK-3) inhibitor with an IC50 value of 34 nM for GSK-3α.

Signaling Pathways

Product Type

GSK-3 Glycogen synthase kinase 3

Get to Know Us

Customer Support

Resources

Contact Us